![Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001 - Valneva Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001 - Valneva](https://valneva.com/wp-content/uploads/2022/08/VLA2001-301_Homologous-Heterologous_Booster_Data.png)
Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001 - Valneva
![Valneva & Pfizer Report Positive Pediatric, Adolescent Phase 2 Booster Results for VLA15 - Lyme Disease Association Valneva & Pfizer Report Positive Pediatric, Adolescent Phase 2 Booster Results for VLA15 - Lyme Disease Association](https://lymediseaseassociation.org/wp-content/uploads/2022/12/vaccine-g2e14d8175_1920.jpg)
Valneva & Pfizer Report Positive Pediatric, Adolescent Phase 2 Booster Results for VLA15 - Lyme Disease Association
![Notifications for Medical and Pharmaceutical Professionals - CHMP Recommends Marketing Authorisation of the COVID-19 Vaccine Valneva also for Booster Vaccinations - Paul-Ehrlich-Institut Notifications for Medical and Pharmaceutical Professionals - CHMP Recommends Marketing Authorisation of the COVID-19 Vaccine Valneva also for Booster Vaccinations - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/valneva-durability.jpg?__blob=thumbnail&v=4)
Notifications for Medical and Pharmaceutical Professionals - CHMP Recommends Marketing Authorisation of the COVID-19 Vaccine Valneva also for Booster Vaccinations - Paul-Ehrlich-Institut
![Valneva COVID shot shelf life extended; gets EMA nod for booster; shows efficacy in trials | Seeking Alpha Valneva COVID shot shelf life extended; gets EMA nod for booster; shows efficacy in trials | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1289345741/image_1289345741.jpg?io=getty-c-crop-4-3)
Valneva COVID shot shelf life extended; gets EMA nod for booster; shows efficacy in trials | Seeking Alpha
![Valneva initiates heterologous booster trial of inactivated, COVID-19 vaccine candidate - Atlanpole Biotherapies : Atlanpole Biotherapies Valneva initiates heterologous booster trial of inactivated, COVID-19 vaccine candidate - Atlanpole Biotherapies : Atlanpole Biotherapies](https://www.atlanpolebiotherapies.eu/wp-content/uploads//2017/04/valneva.jpg)